Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.24.3
Stockholders’ Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 04, 2024
Aug. 22, 2023
Jan. 05, 2023
Jan. 31, 2022
Mar. 31, 2024
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]                
Common stock, shares authorized           1,000,000,000   1,000,000,000
Common stock, par value           $ 0.0001   $ 0.0001
Common stock, shares outstanding           11,738,650   3,851,448
Gross proceeds from issuance of common stock           $ 42,193 $ 6,879  
Sale of stock         2,696,000 3,611,187    
Aggregate net proceeds received           $ 22,159    
Transaction costs           686    
Common stock, remaining amount issuable           $ 100,400    
Gross proceeds from offering         $ 22,600      
Transaction costs         $ 1,880      
Stock repurchase program authorized     5,000,000          
Treasury stock repurchased, shares     10,130          
Treasury stock repurchase price     $ 502       $ 502  
PreFunded Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Purchase of warrants         974,000      
At Market Issuance Sales Agreement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Common stock, par value       $ 0.0001        
Gross proceeds from issuance of common stock       $ 100,000        
Equity Distribution Agreement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Common stock, par value $ 0.0001              
Gross proceeds from issuance of common stock $ 120,000              
Stock Purchase Agreement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Aggregate net proceeds received   $ 30,000            
Agreement term   24 years